Life ScienceCompany
Roivant Sciences M&A Summary
Roivant Sciences has acquired 1 company, including 1 in the last 5 years. It has also divested 2 assets.
Roivant Sciences’ largest acquisition to date was in 2021, when it acquired Silicon Therapeutics for $450M. It’s largest disclosed sale occurred in 2023, when it sold Telavant Holdings to Roche Holding AG for $7.1B. Roivant Sciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Roivant Sciences Business Overview
Where is Roivant Sciences headquartered?
Roivant Sciences is headquartered in London, United Kingdom.
What is Roivant Sciences’ revenue?
Roivant Sciences disclosed revenue of 125M USD for 2024 and 61M USD for 2023.
How many employees does Roivant Sciences have?
Roivant Sciences has 908 employees.
What sector is Roivant Sciences in?
Roivant Sciences is a life science company.
When was Roivant Sciences founded?
Roivant Sciences was founded in 2014.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity1
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 2